4 February 2022 - CADTH is pleased to announce it is expanding its expertise in the management of pharmaceuticals in ...
3 February 2022 - A stakeholder consultation forum for the post-market review of opiate dependence treatment program medicines will be ...
12 November 2021 - In June 2021, the Drug Utilisation Sub-Committee and the Economics Sub-Committee of the PBAC considered the report ...
17 August 2021 - The public consultation process for the post-market review of opiate dependence treatment program medicines is now ...
5 July 2021 - This project has been established to enhance the adverse event reporting processes. ...
21 June 2021 - The US FDA "may require” or seek agreement from sponsors to conduct post-marketing studies to analyse ...
7 June 2021 - The draft report for the post-market review of medicines for smoking cessation is available for public comment ...
28 May 2021 - On 24 March 2021 it was announced the Department of Health will conduct a post-market review ...
24 March 2021 - The Department of Health will conduct a post-market review of the medicines available under the Pharmaceutical ...
15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...
21 December 2020 - A plain language summary for the post-market review of the use of biologics in the treatment ...
9 November 2020 - A Stakeholder Forum will be held via webinar for the post-market review of medicines for smoking cessation ...
25 May 2020 - The final report and outcomes of the post-market review of pulmonary arterial hypertension medicines are now publicly ...
13 March 2020 - The final terms of reference of the post-market review of medicines for smoking cessation are now ...
24 October 2019 - A public consultation process for the post-market review of medicines for smoking cessation will be open ...